Biomaterial-based Treatments for Ocular Diseases
Synakis has developed a novel hydrogel specifically designed for ocular delivery. Our biomaterial is injectable, biocompatible, biodegradable, non-swelling and transparent.
We are developing our biomaterial as a vitreous substitute for vitreoretinal surgery and to deliver engineered therapeutics to treat leading causes of blindness.
Upcoming Events
Want to learn more about Synakis or meet our team? Catch us at these exciting upcoming events!